Omixon
Biotechnology, 460 Horizon Dr Ste 400, Suwanee, Georgia, 30024, United States, 51-200 Employees
Phone Number: +16*********
Who is OMIXON
Omixon is a global transplantation diagnostic company with a mission to provide histocompatibility laboratories with innovative technologies to improve transplant outcomes. Omixon is head...
Read More
-
Headquarters: 460 Horizon Dr Ste 400, Suwanee, Georgia, 30024, United States
-
Date Founded: 2011
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 5122
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Omixon
Answer: Omixon's headquarters are located at 460 Horizon Dr Ste 400, Suwanee, Georgia, 30024, United States
Answer: Omixon's phone number is +16*********
Answer: Omixon's official website is https://omixon.com
Answer: Omixon's revenue is $50 Million to $100 Million
Answer: Omixon's SIC: 5122
Answer: Omixon has 51-200 employees
Answer: Omixon is in Biotechnology
Answer: Omixon contact info: Phone number: +16********* Website: https://omixon.com
Answer: Omixon is a global transplantation diagnostic company with a mission to provide histocompatibility laboratories with innovative technologies to improve transplant outcomes. Omixon is headquartered in Budapest, Hungary, with operations in the United States, Brazil and the Netherlands serving more than 100 laboratories worldwide. Building on multidisciplinary competences in bioinformatics, software engineering, molecular biology and regulatory science, Omixon transforms molecular biology innovations into state-of-the-art products in transplant diagnostics. Omixon was the first to successfully introduce NGS-based HLA typing kit and software in 2014 by bringing Holotype HLA, an NGS-based HLA genotyping product, and HLA Twin software to market. Omixon Twin delivers the most accurate high-resolution HLA genotyping and is used in more than 100+ laboratories worldwide. Omixon was the first to release a high-resolution HLA genotyping product NanoTYPE HLATM with less than 5 hours turnaround time on the Oxford Nanopore sequencing platform complemented by NanoTYPERTM analysis software. Omixon is the first to bring to market the first donor-derived cell-free DNA kit HoloGRAFT for laboratories with donor-informative genetic markers with primer and probe sequences that are absent in the patient genotype by design.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month